Evidence map›Paper›PMID 41010398›Full record

ArticleLife (Basel, Switzerland)2025

Lower ANXA3 Levels May Be Related to Major Depressive Disorder.

Mine Büşra Bozkürk, Kadir Özdel, Bilge Ozan Çiçek, Özkan Önder, Selin Yıldız, Alpaslan Öztürk

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mine Büşra BozkürkAnkara Etlik City Hospital, Department of Clinical Biochemistry, 06170 Ankara, Türkiye.ORCID 0000-0002-9329-3513
Kadir ÖzdelAnkara Etlik City Hospital, Department of Psychiatry, 06170 Ankara, Türkiye.
Bilge Ozan ÇiçekAnkara Etlik City Hospital, Department of Clinical Biochemistry, 06170 Ankara, Türkiye.ORCID 0009-0008-6703-077X
Özkan ÖnderAnkara Etlik City Hospital, Department of Clinical Biochemistry, 06170 Ankara, Türkiye.ORCID 0009-0005-3782-7751
Selin YıldızAnkara Etlik City Hospital, Department of Clinical Biochemistry, 06170 Ankara, Türkiye.
Alpaslan ÖztürkAnkara Etlik City Hospital, Department of Clinical Biochemistry, 06170 Ankara, Türkiye.ORCID 0000-0003-4525-3477

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Annexin A3 (ANXA3) is a calcium-binding protein that plays a role in membrane phospholipid metabolism and inflammation, and significant alterations have been shown in some psychotic disorders. Because its association with major depressive disorder (MDD) is unclear, we aimed to compare serum ANXA3 levels in patients with MDD and healthy controls and to investigate their relationship with depression severity. Serum ANXA3 concentrations in 90 patients diagnosed with MDD and 90 healthy controls were measured by ELISA. Depression severity was assessed using the Beck Depression Inventory (BDI). Serum ANXA3 levels were significantly lower in patients with MDD compared to controls (

Indexed as

Annexin A3biomarkerdepression severitymajor depressive disorder

Identifiers

PMID41010398
PMCPMC12471239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.